CNS Pharmaceuticals, Inc. (CNSP) stock
Close on Nov 13, 2026Market cap $4.22MP/E –Yield –
CNS Pharmaceuticals statistics
60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.23
- 2.22
Share statisticsIndustry
- Shares Change (QoQ)
- 80.1%
- 0.50%
- Float
- 1M
- 49M
- Shares Held by Insiders
- 26.5%
- 11.7%
- Shares Held by Institutions
- 19.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 1,638
- –
- Short Interest Change
- 26.0%
- -0.80%
- Short % of Float
- 0.15%
- 9.01%
- Short % of Shares Outstanding
- 0.11%
- 6.30%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $10.54
- –
- 52-Week Low
- $1.90
- –
- 20-Day Moving Average
- $4.38
- –
- 50-Day Moving Average
- $4.96
- –
- 200-Day Moving Average
- $4.46
- –
- Average True Range (14)
- $0.47
- –
- Price Change (1 Week)
- -26.3%
- -1.15%
- Price Change (1 Month)
- -44.2%
- -4.87%
- Price Change (3 Months)
- -46.5%
- -21.0%
- Price Change (6 Months)
- -41.6%
- -20.6%
- Price Change (YTD)
- -45.0%
- -23.6%
- Price Change (1 Year)
- -56.1%
- -22.4%
- Price Change (3 Years)
- -100.0%
- -29.5%
- Price Change (5 Years)
- -100.0%
- -77.9%
- Average Volume (10 Days)
- 8,196
- –
- Average Volume (20 Days)
- 17,997
- –
- Average Volume (90 Days)
- 8,973
- –
- Relative Volume
- 2.04
- 0.70
- Relative Strength Index (14)
- 24.2
- 43.4
- Volatility (1 Year)
- 254.4%
- 80.1%
- Beta (5 Years)
- 1.63
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -106.6%
- -49.9%
- Return on Assets (ROA)
- -91.6%
- -40.6%
- Return on Capital Employed (ROCE)
- -92.9%
- -37.9%
Financial positionIndustry
- Current Ratio
- 5.86
- 3.30
- Quick Ratio
- 5.35
- 2.39
- Interest Coverage
- -1131.57
- -6.35
EfficiencyIndustry
- Profits Per Employee
- -$2.09M
- -$689.41K
- Employee Count
- 8
- 74
- WACC
- 13.2%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $19.99M
- $17.76M
- Net Cash Per Share
- $13.67
- $0.80
- Equity (Book Value)
- $18.20M
- $53.89M
- Book Value Per Share
- $12.45
- $1.50
- Tangible Book Value
- $18.20M
- $27.13M
- Working Capital
- $18.19M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -395.4%
- -21.8%
Taxes and interestIndustry
- Interest Expense
- $14.95K
- $2.90M
Scores and fair valueIndustry
- Altman Z-Score
- -7.75
- 0.23
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | CNSP | S&P 500 | Difference | CNSP per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -46.0% | -3.0% | −42.9 pts | ||
| 3 months | -43.9% | -2.8% | −41.1 pts | ||
| Year to date | -45.0% | +11.5% | −56.4 pts | ||
| 1 year | -55.2% | +13.5% | −68.7 pts | ||
| 3 years | -100.0% | +77.7% | −177.7 pts | -96.1% | +21.1% |
| 5 years | -100.0% | +72.6% | −172.6 pts | -92.4% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M CNSP shares were sold short on Oct 30, 2026, up 26.0% from the previous report, or 0.15% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 36.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,638 | +26.0% | 23,863 | 1.0 |
| Oct 15, 2026 | 1,300 | +44.8% | 4,301 | 1.0 |
| Sep 30, 2026 | 898 | -69.8% | 3,007 | 1.0 |
| Sep 15, 2026 | 2,969 | +35.4% | 6,400 | 1.0 |
| Aug 31, 2026 | 2,193 | -82.6% | 10,393 | 1.0 |
| Aug 14, 2026 | 12,595 | +10.7% | 4,427 | 2.9 |
| Jul 31, 2026 | 11,374 | -27.9% | 9,344 | 1.2 |
| Jul 15, 2026 | 15,780 | -56.5% | 9,462 | 1.7 |
| Jun 30, 2026 | 36,287 | -6.2% | 13,264 | 2.7 |
| Jun 15, 2026 | 38,686 | -20.3% | 21,160 | 1.8 |
| May 29, 2026 | 48,551 | +58.7% | 128,880 | 1.0 |
| May 15, 2026 | 30,584 | -21.5% | 7,482,268 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?